Company profile: ADx Neurosciences
1.1 - Company Overview
Company description
- Provider of proprietary biomarker assays and antibody solutions for neurodegenerative diseases, enabling early detection of Alzheimerβs, Parkinsonβs and traumatic brain injury. Delivers custom and monoclonal antibodies (Amyloid-beta, Tau, Synuclein), pharma and IVD solutions from antibody to qualified assay and automated kits, and co-develops commercial immunoassays for clinical and drug development.
Products and services
- Biomarker Assays: State-of-the-art assays quantify Alzheimerβs, Parkinsonβs, and traumatic brain injury biomarkers, enabling early detection and supporting drug development and clinical practice
- IVD Solutions: Automated-platform-ready services supply antibodies and continuous support to develop and implement assays into easy-to-use kits for automated platforms serving pharmaceutical companies and clinics
- Pharma Solutions: IVD-qualified programs develop biomarkers from antibody to qualified assay for in vitro diagnostic use, supporting drug development with robust and scalable assays
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to ADx Neurosciences
Rapport Therapeutics
HQ: United States
Website
- Description: Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPΞ³8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Rapport Therapeutics company profile β
Nautilus Neurosciences
HQ: United States
Website
- Description: Provider of specialty pharmaceutical products and services for the treatment of neurological disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Nautilus Neurosciences company profile β
Cosman Medical
HQ: United States
Website
- Description: Provider of radiofrequency (RF) generators, electrodes, and cannulae for neurosurgery and pain management in interventional anesthesiology and podiatry, leveraging RF nerve ablation with a 60-year track record in medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cosman Medical company profile β
Claret Medical
HQ: United States
Website
- Description: Provider of cerebral vascular protection systems for transcatheter aortic valve implantation (TAVI), surgical, and other interventional procedures, including Claret Medical Montage, a percutaneously delivered dual-filter embolic protection device to capture and remove dislodged debris.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Claret Medical company profile β
Psyadon
HQ: United States
Website
- Description: Provider of discovery and development of new treatments for serious psychiatric and neurological diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Psyadon company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for ADx Neurosciences
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ADx Neurosciences
2.2 - Growth funds investing in similar companies to ADx Neurosciences
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for ADx Neurosciences
4.2 - Public trading comparable groups for ADx Neurosciences
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β